Crowdonomics
WatchlistPortfolio
All companies
NIGHTWARE INC logo

NIGHTWARE INC

Unknown

NightWare, Incorporated

Healthcare · Founded 2019

Visit website

AI-driven, fda-cleared solution for ptsd nightmares

Post-money valuation ⓘ
$22.4M
As of Apr 2025 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price
Total raised
$3,894,433
Crowd $0 · Private $3.9M · 7 rounds since 2019
Latest share price
$0.3445
Section 4(a)(2) · Series B Preferred Stock · Jan 2023 offering price

Financials

FY2022–FY2024 · from SEC filings · hover any figure for its source
$2.0M
−$778K
2022
$4.7M
−$275K
2023
$985K
−$1.1M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 reviewed*
FY2023 reviewed*
FY2024
Income statement
Revenue
$2,003,698
$4,657,997
$984,653
Cost of goods sold
$498,277
$779,610
$72,242
Gross margin
75%
83%
93%
Net income
-$778,422
-$274,724
-$1,073,507
Taxes paid
$2,778
$139
$22,278
Balance sheet
Cash
$953,836
$2,191,637
$882,737
Accounts receivable
$118,157
$5,000
$6,900
Total assets
$1,383,783
$2,760,813
$1,493,333
Short-term debt
$228,290
$348,212
$167,132
Long-term debt
$1,751,976
$0
$0
Total liabilities
$1,980,266
$348,212
$167,132
Other
Headcount
—
7
7

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$22.3M
pre-money
Reg CF · Preferred · Dec 2024

Blue bars are the pre-money valuation the company stated for a priced round.

Cap table

Principal holders% as the filing states it, Apr 30, 2025

  • Grady Hannah6,410,500 Common Stock33.1%of

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Rule 506(b) · Equity · Feb 2026Open
Raised $250KInvestors 1
Rule 506(b) · Equity · Aug 2025Closed
Raised $1.1MInvestors 18
Reg CF · Preferred Stock · Dec 2024Closedvia StartEngine
Raised $0 / $1.2MPost-money $22.4M
Section 4(a)(2) · Series B Preferred Stock · Jan 2023Closed
Raised $1.4M
Rule 506(b) · Equity · Jul 2022Closed
Raised $700KInvestors 6
Rule 506(b) · Convertible Note · Feb 2021Closed
Raised $100KInvestors 1

Team

4 people
Matthew David Tucker
Chief Executive Officer and Board Member
Grady Charles Hannah
Board Member
Michael Joseph Ott
Board Member
Spencer Levy
Principal Accounting Officer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 2 annual reports (FY2024–FY2025)

18 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

View all 11 filings on EDGAR
  • Form DMar 6, 20260001615594-26-000006
    EDGAR
  • Form DSep 2, 20250001615594-25-000095
    EDGAR
  • Form C-UMay 21, 20250001665160-25-001130
    EDGAR
  • Form C-UMay 2, 20250001665160-25-000975
    EDGAR
  • Form C-ARApr 30, 20250001665160-25-000871
    EDGAR
  • Form C/AMar 5, 20250001665160-25-000374
    EDGAR
  • Form C-UDec 26, 20240001665160-24-001891
    EDGAR
  • Form CDec 4, 20240001665160-24-001756
    EDGAR
Source: ManualCIK 0001774677Share price $1.16

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.